ReviewCell reports. Medicine2026
T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges.
Sophie Paczesny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it